MedPath

OXALIPLATIN INJECTION

OXALIPLATIN INJECTION

Approved
DIN Number

02436957

Drug Class

Human

Market Date

Dec 17, 2015

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02436957
AIG Number0152220003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XA03 OXALIPLATIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

OXALIPLATINActive
Strength: 5 MG / ML
Monograph: OXALIPLATIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.